Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01173653 · ClinicalTrials.gov registry record · NA

Smoking Cessation Invention in the Emergency Department (ED)

A NA study, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
199
Enrollment target

NCT01173653 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 199 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01173653, a NA study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
199 participants
Enrollment target

Study Summary

The emergency department (ED) serves a vital and growing role in the US health care system, responsible for both the delivery of emergent medical care and for safety-net care for populations without traditional access to health services. Uninsured populations rely significantly on the safety-net services of the ED. Between 2000-2005 the number of uninsured Americans increased from 39.6 million to 46.1 million, and this growth is expected to continue. Many health policy analysts consider the ED to be an effective place to provide preventative care. Prophylactic tetanus immunization, for example, has been a successful preventive health intervention that has become a standard of care in the ED setting. Brief smoking cessation interventions have been introduced in the ED but have not had great success based on lack of follow-up and continuity. Our study is novel in that it introduces a brief smoking intervention through use of an established, federally-funded and federally-sponsored cessation counseling resource, the National Smoking Cessation Quit Line, also available at smokefree.gov. This is a joint initiative between the Tobacco Control Research Branch of the National Cancer Institute and the Centers for Disease Control and Prevention. Since ED patients who smoke often lack the ability to use self-help cessation resources, we hypothesize that by introducing this population to the counselors on the National Smoking Cessation Quit Line (also called the 1-800-QUIT-NOW line) during the ED visit via phone, that this new brief intervention would have a realizable and significant effect on smoking cessation among the this population.

Interventions

  • OTHER Smoking Cessation

Trial Details

FieldValue
Enrollment Target 199 participants
Start Date 2010-07
Est. Completion 2011-01
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT01173653

The ClinicalTrials.gov registry entry for NCT01173653 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Smoking Cessation is the first listed.

NCT01173653 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01173653 about?

NCT01173653 is a clinical study titled "Smoking Cessation Invention in the Emergency Department (ED)". The emergency department (ED) serves a vital and growing role in the US health care system, responsible for both the delivery of emergent medical care and for safety-net care for populations without traditional access to health services. Uninsured populations rely significantly on the safety-net ser...

What is the current status of trial NCT01173653?

This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2010-07. Estimated completion is 2011-01.

What interventions are being tested in trial NCT01173653?

The interventions under investigation include: Smoking Cessation (OTHER).

Who is sponsoring clinical trial NCT01173653?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.